MEDIPOST’s treatment for knee osteoarthritis, enters phase 3 clinical trials in Japan2022/03/25STEM CELL THERAPEUTIC
MEDIPOST’s phase 1 clinical trial results for its injectable drug for knee osteoarthritis in Korea show improvements in safety and clinical symptoms2021/03/22STEM CELL THERAPEUTIC
MEDIPOST receives approval for processing the phase 3 clinical trial of CARTISTEM in Japan2021/02/15STEM CELL THERAPEUTIC
MEDIPOST completes the phase 1 clinical trial of its injectable drug for knee osteoarthritis, SMUP-IA-012020/11/16STEM CELL THERAPEUTIC
MEDIPOST’s Clinical Trial of Next-Generation Cell Therapy Product ‘SMUP-IA-01’ Makes Solid Progress2020/05/21STEM CELL THERAPEUTIC
